** Shares of Nova Eye Medical EYE.AX rise 12% to A$0.140, their highest point since June 2
** The medical technology co recorded FY25 revenue of A$28.8 million ($18.75 million), up 21% from FY24 and within its forecast range of A$27.5 mln to A$29.1 mln
** Expects revenue growth to continue in FY26
** Stock set for best day since April 10, if gains hold
** About 923,160 shares change hands, 2.3x the 30-day average of 407,493
** Stock down 21.9% YTD, including moves in current session
($1 = 1.5359 Australian dollars)
(Reporting by Jasmeen Ara Shaikh in Bengaluru)
((JasmeenAraIslam.Shaikh@thomsonreuters.com;))